Melanoma Research

Transforming How Clinical Benefits Are Achieved

AIM at Melanoma understands that breakthroughs happen when you engage the right people, promote innovative ideas, and provide access to cutting-edge research tools and resources. Our global initiatives are fundamentally changing the face and future of research to advance the discovery of the CURE.

AIM at Melanoma Research Efforts

Our International Melanoma Tissue Bank Consortium (IMTBC) is the first multi-institutional tissue bank of its kind for melanoma.

International Melanoma Working Group

Bringing together leading researchers to reshape the future of melanoma treatment

Learn More »

Brain Metastases Tissue Bank & Clinical Trial

Providing researchers with the resources needed to continue this important work

Collaborative Adaptive Trials (MICAT)

Creating collaborative among researchers and industry to find faster, more effective melanoma treatments

International Melanoma Tissue Bank

Creating the first international bank with fresh frozen primary melanoma tissue for public and private research

Learn More »

With the Donations,  We Have Achieved:

research-imwg

International Melanoma Tissue Bank Consortium (IMTBC):

  • IMTBC is the first multi-institutional tissue bank of its kind for melanoma.
  • IMTBC contains fresh frozen samples of primary melanoma tumor tissue for research.
  • Researchers across the globe will have access to these vital tissues.
  • AIM is paving the way for major advancements in the field of melanoma.

 

Together we have made progess. Let’s continue to reshape melanoma research.

Related Content

Global Advocacy

The most influential voice in melanoma, locally and globally

AIM Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through groundbreaking research, legislative reform, education, and patient and caregiver support.

Get Involved

AIM is dedicated to finding the cure by transforming clinical research.

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

  • This field is for validation purposes and should be left unchanged.